Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam concentrations in plasma and subcutis in CRRT patients
2017-000717-24Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Feb 2017
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of piperacillin + tazobactam in bacterial disease, sponsored by Aarhus University Hospital. Primary endpoints: Time above MIC in plasma and Time above MIC in subcutis. Started Feb 2017; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2017-000717-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000717-24.